Navigation Links
Studies of Drug Resistance May Lead to Individual Therapy for Rare,Cancers

WASHINGTON, January 29, 2007 /PRNewswire-USNewswire/ -- Rear Admiral Timothy Ziemer (U.S. Navy, retired), the President's Malaria Coordinator, announced his intent to name Dr. Bernard Nahlen to serve as Deputy Coordinator of the President's Malaria Initiative (PMI). Dr. Nahlen is a Commissioned Officer in the U.S. Public Heath Service and has most recently served as Senior Advisor, Monitoring and Evaluation, at the Global Fund to Fight AIDS, Tuberculosis and Malaria.

As Deputy Coordinator, Dr. Nahlen will assist the Coordinator in directing the PMI, an historic $1.2 billion, five-year initiative announced by President Bush in 2005 to control malaria in Africa. His specific responsibilities will include serving as the Senior Technical Advisor to the Coordinator providing guidance on malaria technical issues and program interventions; assisting in country programs, program facilitation, policy coordination, coherence and implementation among all U.S. Government (USG) agencies and other recipients of USG funds for malaria prevention and treatment.

The goal of the PMI is to assist national malaria control programs to cut malaria-related deaths by 50 percent in fifteen target countries in Africa. This goal will be achieved by reaching 85 percent of the most vulnerable groups -- children under five years of age and pregnant women -- with proven and effective prevention and treatment control measures. PMI uses a comprehensive approach to prevent and treat malaria supporting four key areas; indoor spraying of homes with insecticides, insecticide-treated mosquito nets, lifesaving anti-malarial drugs, and treatment to prevent malaria in pregnant women. The initiative is a collaborative USG effort led by the U.S. Agency for International Development (USAID), in conjunction with the Department of Health and Human Services (Centers for Disease Control and Prevention), the Department of State, the White House, and others.

Dr. Nahlen was born in Little Rock, Arkansas, where he graduated from medical school after completing undergraduate studies at the University of Notre Dame. He completed a residency in Family Practice at the University of California at San Francisco before joining the Centers for Disease Control and Prevention in 1986 as an Epidemic Intelligence Officer assigned to the Malaria Branch. In 1989 he completed a second residency in Preventive Medicine and was later served as Deputy Director of the Los Angeles County AIDS Epidemiology Program.

For more information about USAID's malaria programs and the PMI, please visit: http://www.usaid.gov/our_work/global_health/id/malaria/index.html

Public Information: 202-712-4810

CONTACT: U.S. Agency for International Development Press Office:+1-202-712-4320

Web site: http://www.usaid.gov//

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Related medicine technology :

1. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
2. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
3. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
4. Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants
5. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
6. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
7. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
8. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
9. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
10. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
11. Neurogen Proprietary Insomnia Compound Data for Two Studies Presented at Associated Professional Sleep Societies Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
Breaking Medicine News(10 mins):